Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 426
interventional 329
Observational 84
Registry 13

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 103
Drug|placebo 101
Other 23
Behavioral 22
Biological|placebo 21
Biological 20
Procedure 9
Device 5
Biological|Drug|placebo 3
Drug|Other|placebo 3
Device|Procedure 2
Dietary Supplement 2
Dietary Supplement|placebo 2
Drug|Other 2
Genetic 2
Behavioral|Drug 1
Behavioral|Other 1
Biological|Device 1
Biological|Drug|Other|Procedure 1
Biological|Other 1
Biological|Other|placebo 1
Combination Product 1
Device|Drug|Other 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 119
France 18
China 17
NA 17
United States|Canada 9
Japan 8
Germany 7
United Kingdom 7
Brazil 5
Netherlands 5
Spain 5
Canada 4
Hong Kong 3
Chile 2
Egypt 2
Iran, Islamic Republic of 2
Israel 2
Mexico 2
United States|Belgium|Brazil|Hong Kong|Hungary|India|Lithuania|Poland|Spain|Ukraine|United Kingdom 2
United States|Mexico 2
Argentina|Australia|Brazil|Chile|Colombia|Hong Kong|India|Korea, Republic of|Peru|Philippines|Romania|Russian Federation|Taiwan 1
Argentina|Australia|China|Czechia|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan|Thailand 1
Argentina|Austria|Belgium|Brazil|Canada|Chile|Colombia|Czechia|France|Germany|Hong Kong|India|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Peru|Philippines|Poland|Puerto Rico|Romania|Russian Federation|Slovakia|Spain|Sweden|Taiwan|United Kingdom 1
Australia 1
Austria|Bulgaria|France|Germany|Italy|Mauritius|Mexico|Portugal|Romania|Spain 1
Belarus 1
Belarus|Georgia|Poland|Serbia 1
Belgium 1
Belgium|Bulgaria|Croatia|France|Germany|Switzerland 1
Belgium|Bulgaria|Germany 1
China|Japan|Korea, Republic of 1
Colombia|United States|Argentina|Brazil|Chile|Hong Kong|India|Mexico|Peru|Philippines|Taiwan 1
Czech Republic 1
Denmark 1
Denmark|Sweden 1
France|United States|Australia|Belgium|Brazil|Bulgaria|Canada|Czechia|Estonia|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
Georgia|United States|Bulgaria|Czechia|France|Germany|Hungary|Israel|Italy|Mexico|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
Germany|Bulgaria|Belgium|Poland|Romania|Russian Federation|Spain 1
Germany|Greece|Italy 1
Greece 1
Hungary|United States|Brazil|Canada|France|Germany|India|Italy|Mexico|Poland|Romania|Russian Federation|South Africa|Spain|Ukraine|United Kingdom 1
Japan|Korea, Republic of 1
Japan|United States|Argentina|Australia|Brazil|Canada|Colombia|France|Germany|Hungary|Israel|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Spain|Taiwan 1
Japan|United States|Australia|Bulgaria|Czechia|France|Germany|Hungary|Italy|Korea, Republic of|Mexico|Poland 1
Mexico|United States|Argentina|Chile|Peru 1
Mexico|United States|Argentina|Colombia|Poland|Russian Federation 1
Philippines|Belarus|Brazil|Colombia|Georgia|Guatemala|Hong Kong|India|Korea, Republic of|Malaysia|Mexico|Russian Federation|Singapore|Sri Lanka|Taiwan|Thailand 1
Philippines|United States|Argentina|Brazil|Chile|Colombia|Hong Kong|India|Mexico|Peru|Taiwan 1
Romania|United States|Argentina|Brazil|Bulgaria|Canada|Chile|France|Germany|Hungary|India|Italy|Jamaica|Mexico|Netherlands|Peru|Philippines|Poland|South Africa|Spain|Thailand|United Kingdom 1
Sweden 1
Taiwan 1
Turkey 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Chile|China|Colombia|Croatia|Czechia|France|Germany|Greece|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Philippines|Poland|Romania|Russian Federation|Serbia|South Africa|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Bulgaria|Croatia|Czech Republic|France|Germany|Greece|India|Israel|Korea, Republic of|Latvia|Lebanon|Lithuania|Malaysia|Mexico|Netherlands|Philippines|Poland|Russian Federation|Serbia|South Africa|Spain|Switzerland|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|France|Germany|Mexico|Netherlands|Poland|Spain|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Estonia|Hong Kong|Hungary|Indonesia|Italy|Korea, Republic of|Lithuania|Malaysia|Mexico|New Zealand|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Switzerland|Taiwan|Thailand|Ukraine 1
United States|Argentina|Australia|Brazil|Canada|Colombia|Germany|Hungary|Israel|Japan|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Spain|Taiwan 1
United States|Argentina|Australia|Brazil|Chile|Colombia|Germany|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Peru|Poland|Romania|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Bulgaria|Canada|Chile|Colombia|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Lithuania|Mexico|Peru|Poland|Romania|Russian Federation|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Australia|Germany|Hungary|Mexico|Poland|Spain|Taiwan 1
United States|Argentina|Austria|Belarus|Bulgaria|Canada|Chile|Colombia|Croatia|Egypt|Germany|Guatemala|Italy|Japan|Korea, Republic of|Macedonia, The Former Yugoslav Republic of|Peru|Philippines|Poland|Puerto Rico|Singapore|Thailand|Ukraine 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Chile|Colombia|Croatia|Czechia|Denmark|France|Germany|Hungary|Italy|Japan|Malaysia|Mexico|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Spain|Sweden|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Argentina|Austria|France|Japan|Korea, Republic of|Mexico|Poland|Puerto Rico|Romania|Spain|Taiwan 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|France|Germany|Japan|Korea, Republic of|Lithuania|Mexico|Russian Federation|South Africa|Spain 1
United States|Argentina|Belgium|Brazil|Canada|Colombia|France|Germany|Hungary|Italy|Mexico|Poland|Russian Federation|Serbia|Spain 1
United States|Argentina|Brazil|Bulgaria|Chile|Colombia|Germany|Korea, Republic of|Mexico|Spain|Taiwan|United Kingdom 1
United States|Argentina|Brazil|Bulgaria|Chile|Colombia|Korea, Republic of|Mexico|Spain|Taiwan|United Kingdom 1
United States|Argentina|Brazil|Bulgaria|Chile|Czechia|Germany|Italy|Japan|Korea, Republic of|Mexico|Peru|Philippines|Poland|Russian Federation|South Africa|Spain|United Kingdom 1
United States|Argentina|Brazil|Canada|Chile|Colombia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Netherlands|Peru|Poland|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Taiwan 1
United States|Argentina|Brazil|Canada|France|Germany|Korea, Republic of|Mexico|Netherlands|Russian Federation|Spain 1
United States|Argentina|Brazil|Chile 1
United States|Argentina|Bulgaria|Canada|China|Colombia|Ecuador|France|Germany|Hungary|Japan|Korea, Republic of|Lithuania|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|South Africa|Spain|Taiwan|Thailand|Ukraine 1
United States|Argentina|Bulgaria|Chile|Colombia|Germany|Italy|Japan|Korea, Republic of|Malaysia|Mauritius|Mexico|Peru|Philippines|Poland|Romania|Russian Federation|South Africa|Taiwan 1
United States|Argentina|Bulgaria|Colombia|Georgia|Hungary|Mexico|Peru|Philippines|Poland|Romania|Ukraine 1
United States|Argentina|Bulgaria|Colombia|Israel|Korea, Republic of|Mexico|Philippines|Poland|Serbia|Taiwan|Thailand 1
United States|Argentina|Canada|Japan|Mexico|Peru|Poland|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Chile|Colombia|France|India|Italy|Japan|Korea, Republic of|Philippines|Poland|Romania|Serbia|South Africa|Spain 1
United States|Argentina|Chile|Colombia|Germany|Hungary|Korea, Republic of|Moldova, Republic of|Peru|Poland|Puerto Rico|Romania|Taiwan 1
United States|Argentina|Chile|Czechia|Germany|Hungary|Korea, Republic of|Mexico|Peru|Philippines|Poland|Portugal|Russian Federation|Serbia|Spain|Taiwan|Ukraine 1
United States|Argentina|Germany|Japan|Netherlands|Spain 1
United States|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Italy|Korea, Republic of|Mexico|Puerto Rico|South Africa|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|China|Croatia|Czechia|Germany|Greece|Hungary|Israel|Mexico|Netherlands|Russian Federation|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Belgium|Brazil|Bulgaria|Czechia|Estonia|France|Germany|India|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Puerto Rico|Romania|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Bulgaria|Canada|Colombia|Czechia|France|Germany|Greece|Hungary|Japan|Korea, Republic of|Mexico|Poland|Portugal|Romania|Spain|Taiwan|Ukraine 1
United States|Australia|Brazil|Canada|Ecuador|France|Hungary|India|Israel|Latvia|Malaysia|Mexico|New Zealand|Romania|Russian Federation|Serbia|South Africa|Spain|Taiwan|Tunisia|United Kingdom 1
United States|Australia|Colombia|Mexico 1
United States|Australia|Denmark|France|Germany|Malaysia|Taiwan|United Kingdom 1
United States|Austria|Belgium|Canada|Costa Rica|Czech Republic|France|Germany|Israel|Italy|Mexico|Netherlands|Poland|Puerto Rico|Romania|Slovakia|Spain|Sweden|United Kingdom 1
United States|Austria|Canada|France|Germany|Italy|Mexico|Spain|Sweden|United Kingdom 1
United States|Belarus|Bulgaria|Georgia|Russian Federation|Ukraine 1
United States|Belgium|Czech Republic|France|Germany|Hungary|Poland|Portugal|Spain|Ukraine|United Kingdom 1
United States|Belgium|Moldova, Republic of|Poland|Romania|Spain|Taiwan 1
United States|Brazil 1
United States|Brazil|Bulgaria|Colombia|Czech Republic|Hungary|India|Korea, Republic of|Mexico|Peru|Poland|Romania|Taiwan|Ukraine 1
United States|Brazil|Bulgaria|Colombia|Czechia|Hungary|Korea, Republic of|Mexico|Peru|Poland|Romania|Taiwan|Ukraine 1
United States|Brazil|Canada|Chile 1
United States|Brazil|Colombia|France|South Africa|United Kingdom 1
United States|Bulgaria 1
United States|Bulgaria|Chile|Colombia|Germany|Hungary|Mexico|Peru|Poland|Romania|Russian Federation|Spain|Ukraine 1
United States|Canada|France|Russian Federation|United Kingdom 1
United States|China|Japan|Korea, Republic of 1
United States|Czechia|France|Germany|Hungary|Mauritius|Poland|Puerto Rico 1
United States|Czechia|France|Germany|Hungary|Mauritius|Puerto Rico 1
United States|France|Germany|Poland 1
United States|France|Hong Kong|Malaysia|Mexico 1
United States|Germany|Mexico|Puerto Rico 1
United States|Hungary|Korea, Republic of|Poland 1
United States|Poland|Spain 1
United States|Puerto Rico 1
United States|Taiwan|Argentina|Australia|Canada|China|Colombia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Poland|Puerto Rico|Spain|United Kingdom 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 160
2 22
3 6
4 4
5 3
6 7
7 6
8 4
9 1
10 4
11 2
12 2
13 3
14 5
15 6
16 3
17 3
18 2
19 5
20 1
21 3
22 4
23 3
25 1
26 2
27 2
29 1
30 2
31 1
32 1
35 2
39 1
42 1
44 1
47 1
51 1
52 1
53 1
54 1
57 3
62 1
65 1
68 1
70 1
71 2
72 1
74 1
79 3
80 1
82 1
84 1
90 1
92 1
96 1
110 2
113 3
116 1
118 1
121 1
129 1
133 3
138 2
141 1
146 2
152 1
157 1
175 1
177 1
185 1
187 1
192 2
207 1
228 1
252 1
277 1
364 1

Phase

Phase Study_Count
Phase 2 102
N/A 76
Phase 1 62
Phase 3 35
Phase 4 24
Phase 1/Phase 2 19
Phase 2/Phase 3 7
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 66
2 128
3 43
4 27
5 15
6 7
7 2
10 1
14 1
19 1
NA 38

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0 5.0000 6.00000 1.00000 9.0000 13.0000 62.0000 10.0000
1st Qu. 11.5 30.0000 21.50000 17.50000 30.0000 42.0000 244.5000 68.7500
Median 14.0 71.0000 38.50000 30.00000 75.0000 118.0000 381.0000 103.0000
Mean 34.5 135.6316 47.96774 57.89474 148.1287 161.1429 504.7143 312.9167
3rd Qu. 37.0 168.5000 59.50000 102.50000 218.0000 226.0000 770.5000 210.0000
Max. 100.0 970.0000 264.00000 186.00000 834.0000 461.0000 1250.0000 4019.0000

Trial Group Type

group_type Group_Count
Experimental 446
Placebo Comparator 144
Active Comparator 90
NA 38
No Intervention 28
Other 21
Sham Comparator 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 203
Single Group Assignment 93
NA 12
Crossover Assignment 10
Sequential Assignment 7
Factorial Assignment 4

Primary Purpose

primary_purpose Study_Count
Treatment 248
Prevention 22
Supportive Care 13
Diagnostic 12
Basic Science 10
Other 10
Health Services Research 7
NA 6
Educational/Counseling/Training 1

Observational Studies

Studies by Country

Country Study_Count
United States 35
France 13
NA 11
China 4
Germany 3
Canada 2
Spain 2
Taiwan 2
Denmark 1
Egypt 1
Iran, Islamic Republic of 1
Italy 1
Japan 1
Singapore 1
Spain|United Kingdom|United States|Australia|Canada|France|Germany|Italy 1
United Kingdom 1
United States|Canada 1
United States|Canada|United Kingdom 1
United States|Germany|Mexico|Poland|Taiwan|United Kingdom 1
United States|Poland 1

Sites per Study

Site_count Study_Count
1 67
2 5
3 5
4 1
6 1
10 2
11 1
21 1
138 1

Enrollment Metrics

Measure Observational
Min 1
1st Qu 60
Median 200
Mean 1205562
3rd Qu 620
Max 99999999

Observation Model

observational_model Study_Count
Cohort 34
Case-Control 17
NA 11
Case-Only 10
Case Control 9
Other 2
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 50
Retrospective 14
Cross-Sectional 12
NA 5
Other 2
Longitudinal 1

Registries

Studies by Country

Country Study_Count
United States 6
France 2
Australia|China|Hong Kong|India|Indonesia|Japan|Korea, Republic of|Malaysia|Philippines|Singapore|Sri Lanka|Taiwan|Thailand|United Arab Emirates 1
Canada 1
China 1
Israel 1
United States|Argentina|Austria|Belgium|Canada|France|Germany|Israel|Italy|Portugal|Slovakia|Spain|Sweden 1

Sites per Study

Site_count Study_Count
1 9
2 1
5 1
24 1
173 1

Enrollment Metrics

Measure Registries
Min 97.000
1st Qu 500.000
Median 662.000
Mean 1850.846
3rd Qu 2000.000
Max 9587.000

Registry Model

observational_model Study_Count
Cohort 10
Case-Only 1
Family-Based 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 12
Cross-Sectional 1

Follow-up

target_duration Study_Count
10 Years 3
1 Day 2
100 Years 1
12 Months 1
12 Years 1
20 Years 1
5 Years 1
6 Months 1
7 Years 1
9 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04461158 CCCR Lupus Patient Navigator Program https://ClinicalTrials.gov/show/NCT04461158 Enrolling by invitation Medical University of South Carolina 2021-07-10
NCT04184258 Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells https://ClinicalTrials.gov/show/NCT04184258 Recruiting Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 2020-12-31
NCT03933943 A Study of LY3361237 in Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03933943 Recruiting Eli Lilly and Company 2021-01-14
NCT03920267 Long-Term Safety and Efficacy Study of BMS-986165 in Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03920267 Recruiting Bristol-Myers Squibb 2022-07-29
NCT03915652 Addressing Disparities in Lupus Care Through an Integrated Care Management Program https://ClinicalTrials.gov/show/NCT03915652 Enrolling by invitation Brigham and Women’s Hospital 2021-01-31
NCT03843125 A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03843125 Recruiting Eli Lilly and Company 2025-05-30
NCT03616964 A Study of Baricitinib in Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03616964 Recruiting Eli Lilly and Company 2021-10-15
NCT03616912 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03616912 Recruiting Eli Lilly and Company 2021-10-30
NCT03517722 A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03517722 Recruiting Janssen Research & Development, LLC 2021-01-22
NCT03407482 An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03407482 Completed Genentech, Inc. 2019-11-20
NCT03312907 A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE https://ClinicalTrials.gov/show/NCT03312907 Active, not recruiting GlaxoSmithKline 2020-05-29
NCT03374618 Neutrophil Extracellular Traps in Systemic Sclerosis https://ClinicalTrials.gov/show/NCT03374618 Recruiting CHU de Reims 2021-10-06
NCT03371251 Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care https://ClinicalTrials.gov/show/NCT03371251 Active, not recruiting Boston Pharmaceuticals 2020-08-31
NCT03288324 Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus https://ClinicalTrials.gov/show/NCT03288324 Recruiting Children’s Hospital Medical Center, Cincinnati 2020-12-31
NCT03262727 The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients https://ClinicalTrials.gov/show/NCT03262727 Completed Bristol-Myers Squibb 2017-11-23
NCT03254784 A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation https://ClinicalTrials.gov/show/NCT03254784 Completed Bristol-Myers Squibb 2017-11-04
NCT03252587 An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03252587 Active, not recruiting Bristol-Myers Squibb 2021-04-04
NCT03248518 Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03248518 Active, not recruiting University of Aberdeen 2020-10-31
NCT03187743 Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone https://ClinicalTrials.gov/show/NCT03187743 Recruiting Assistance Publique - Hôpitaux de Paris 2021-01-31
NCT03186794 Aerobic Exercise in Women With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03186794 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-31
NCT03171194 Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03171194 Completed Medical University of South Carolina 2018-04-30
NCT03161483 A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03161483 Active, not recruiting Celgene 2020-01-21
NCT03159936 Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03159936 Recruiting Tufts Medical Center 2020-06-30
NCT03134222 Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) https://ClinicalTrials.gov/show/NCT03134222 Completed Gilead Sciences 2019-03-13
NCT03122431 Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases https://ClinicalTrials.gov/show/NCT03122431 Recruiting University of Sao Paulo General Hospital 2020-06-01
NCT03103243 Pilot Study to Investigate Contemplative Intervention in Lupus Patients https://ClinicalTrials.gov/show/NCT03103243 Completed University of Virginia 2018-06-04
NCT03093402 JBT-101 in Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03093402 Recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-12-31
NCT03054259 Rituximab Objective Outcome Measures Trial in SLE https://ClinicalTrials.gov/show/NCT03054259 Recruiting University of Leeds 2020-02-29
NCT03042260 Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous https://ClinicalTrials.gov/show/NCT03042260 Recruiting Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2021-02-28
NCT03031925 Detection of Annexin A2 in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03031925 Recruiting Centre Hospitalier Universitaire, Amiens 2018-11-09
NCT03030118 Study of Anti-Malarials in Incomplete Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03030118 Recruiting Milton S. Hershey Medical Center 2021-09-30
NCT03027674 Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud https://ClinicalTrials.gov/show/NCT03027674 Completed Pontificia Universidad Catolica de Chile 2016-08-31
NCT02975336 A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02975336 Active, not recruiting EMD Serono 2019-11-27
NCT02962960 A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations https://ClinicalTrials.gov/show/NCT02962960 Completed AstraZeneca 2018-01-22
NCT02955615 ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02955615 Completed Iltoo Pharma 2018-08-27
NCT02953821 Acthar Gel for Active Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02953821 Completed Mallinckrodt 2019-07-31
NCT02950714 Dissemination of the Lupus Interactive Navigator https://ClinicalTrials.gov/show/NCT02950714 Completed CHU de Quebec-Universite Laval 2018-07-31
NCT02932137 Anti-infection of Low-does IL-2 in SLE https://ClinicalTrials.gov/show/NCT02932137 Completed Peking University People’s Hospital 2016-12-16
NCT02927457 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects https://ClinicalTrials.gov/show/NCT02927457 Completed GlaxoSmithKline 2018-06-12
NCT02925351 Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases https://ClinicalTrials.gov/show/NCT02925351 Completed Jonsson Comprehensive Cancer Center 2018-04-30
NCT02922114 Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients https://ClinicalTrials.gov/show/NCT02922114 Completed Centre Hospitalier Régional d’Orléans 2015-03-31
NCT04453215 Dental Implant Therapy for Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04453215 Completed Istanbul University 2019-12-23
NCT02885610 Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) https://ClinicalTrials.gov/show/NCT02885610 Completed RemeGen 2019-06-11
NCT02875691 Effect of Green Tea on Treatment of Lupus https://ClinicalTrials.gov/show/NCT02875691 Completed Ahvaz Jundishapur University of Medical Sciences 2016-03-31
NCT02847598 Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02847598 Completed Biogen 2019-08-28
NCT02842814 Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02842814 Recruiting Peking Union Medical College Hospital 2020-06-30
NCT02822989 Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain https://ClinicalTrials.gov/show/NCT02822989 Enrolling by invitation Northwell Health 2018-04-30
NCT02804763 A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02804763 Completed UCB Pharma 2018-05-31
NCT02799173 Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification https://ClinicalTrials.gov/show/NCT02799173 Completed Centre Hospitalier Universitaire, Amiens 2015-07-01
NCT02794285 Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02794285 Active, not recruiting AstraZeneca 2021-12-14
NCT02756546 Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis https://ClinicalTrials.gov/show/NCT02756546 Completed Cairo University 2015-09-30
NCT02741960 The Effect of Metformin on Reducing Lupus Flares https://ClinicalTrials.gov/show/NCT02741960 Completed RenJi Hospital 2017-12-13
NCT02732470 Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) https://ClinicalTrials.gov/show/NCT02732470 Completed University Hospital, Limoges 2017-04-10
NCT02725515 A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02725515 Completed Xencor, Inc. 2018-07-17
NCT02708095 A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02708095 Completed Eli Lilly and Company 2017-10-12
NCT02677688 Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02677688 Active, not recruiting Nantes University Hospital 2021-09-01
NCT02656082 Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02656082 Completed University of Leeds 2017-12-31
NCT02653287 Lupus Intervention for Fatigue Trial https://ClinicalTrials.gov/show/NCT02653287 Recruiting Northwestern University 2021-12-31
NCT02633163 Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) https://ClinicalTrials.gov/show/NCT02633163 Recruiting Medical University of South Carolina 2021-06-30
NCT02631005 Walk With Ease Program For Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02631005 Completed University of North Carolina, Chapel Hill 2018-04-30
NCT02618967 Single Ascending Dose Study of AMG 570 in Healthy Subjects https://ClinicalTrials.gov/show/NCT02618967 Completed Amgen 2018-10-22
NCT02609789 A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02609789 Completed Janssen Research & Development, LLC 2018-09-30
NCT03098823 A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE https://ClinicalTrials.gov/show/NCT03098823 Completed Ampel BioSolutions, LLC 2019-05-28
NCT02908100 A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02908100 Completed Genentech, Inc. 2019-05-28
NCT02554019 Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02554019 Completed Biotest 2017-10-25
NCT03393013 A Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis https://ClinicalTrials.gov/show/NCT03393013 Recruiting Kezar Life Sciences, Inc. 2021-06-30
NCT02537028 MSC2364447C Phase 1b in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02537028 Completed EMD Serono 2016-10-04
NCT02535689 Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02535689 Completed National Institutes of Health Clinical Center (CC) 2018-04-26
NCT02524795 Omega 3 Fatty Acids and Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02524795 Completed Federal University of Minas Gerais 2012-08-31
NCT02504645 A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02504645 Completed ImmuPharma 2018-01-31
NCT02477150 Safety and Immunogenicity of a Zoster Vaccine in SLE https://ClinicalTrials.gov/show/NCT02477150 Completed Tuen Mun Hospital 2018-11-30
NCT02472795 Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02472795 Completed Idorsia Pharmaceuticals Ltd. 2017-01-23
NCT02455089 Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02455089 Completed University Hospital, Grenoble 2018-02-28
NCT02453880 Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness https://ClinicalTrials.gov/show/NCT02453880 Completed Stanford University 2015-05-31
NCT02446912 Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02446912 Completed AstraZeneca 2018-07-17
NCT02446899 Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02446899 Completed AstraZeneca 2018-09-27
NCT02443506 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02443506 Completed Amgen 2007-04-30
NCT02437890 A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02437890 Completed Ablynx 2018-01-31
NCT02429934 Abatacept for SLE Arthritis (IM101-330) https://ClinicalTrials.gov/show/NCT02429934 Recruiting University of California, Los Angeles 2019-08-01
NCT02411136 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02411136 Completed Amgen 2007-08-31
NCT02391259 A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02391259 Completed Amgen 2011-09-30
NCT02364908 Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus https://ClinicalTrials.gov/show/NCT02364908 Completed University Hospital, Lille 2016-11-30
NCT02330250 Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment https://ClinicalTrials.gov/show/NCT02330250 Completed Oswaldo Cruz Foundation 2016-02-29
NCT02321709 Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients https://ClinicalTrials.gov/show/NCT02321709 Completed Sanofi 2016-03-31
NCT02319525 Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus https://ClinicalTrials.gov/show/NCT02319525 Completed University of Alabama at Birmingham 2016-11-30
NCT02307643 Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients https://ClinicalTrials.gov/show/NCT02307643 Completed Mitsubishi Tanabe Pharma Corporation 2017-05-31
NCT02306629 Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood https://ClinicalTrials.gov/show/NCT02306629 Completed UCB Pharma 2015-04-30
NCT02291588 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02291588 Completed Amgen 2010-03-31
NCT02284984 Synergetic B-cell Immodulation in SLE https://ClinicalTrials.gov/show/NCT02284984 Completed Leiden University Medical Center 2018-10-31
NCT02281513 Activity and Nutrition Trial in Lupus to Energize and Renew https://ClinicalTrials.gov/show/NCT02281513 Active, not recruiting Northwestern University 2015-04-30
NCT02270957 Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches https://ClinicalTrials.gov/show/NCT02270957 Active, not recruiting Oklahoma Medical Research Foundation 2018-12-31
NCT02265744 Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02265744 Completed Bristol-Myers Squibb 2017-10-26
NCT02194400 Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02194400 Completed Resolve Therapeutics 2015-11-30
NCT02185040 A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. https://ClinicalTrials.gov/show/NCT02185040 Completed Celgene 2018-09-25
NCT02151409 Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects https://ClinicalTrials.gov/show/NCT02151409 Completed Novo Nordisk A/S 2009-10-31
NCT02124798 A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector https://ClinicalTrials.gov/show/NCT02124798 Completed GlaxoSmithKline 2015-04-13
NCT02119156 Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients https://ClinicalTrials.gov/show/NCT02119156 Completed GlaxoSmithKline 2018-12-14
NCT02106897 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 in Healthy Volunteers and Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02106897 Completed Biogen 2016-05-24
NCT02084238 Low-dose IL-2( Interleukin-2) Treatment in SLE https://ClinicalTrials.gov/show/NCT02084238 Completed Peking University People’s Hospital 2014-11-30
NCT01305746 A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 https://ClinicalTrials.gov/show/NCT01305746 Completed Anthera Pharmaceuticals 2013-07-31
NCT01300208 To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01300208 Completed Amgen 2013-01-01
NCT01294774 Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01294774 Completed Novartis 2012-10-31
NCT01283139 A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01283139 Completed MedImmune LLC 2013-11-14
NCT01269866 Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01269866 Completed Brain Resource Center 2012-05-31
NCT03742037 Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03742037 Recruiting Idorsia Pharmaceuticals Ltd. 2021-05-17
NCT03451422 Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03451422 Recruiting Amgen 2021-06-16
NCT03355482 MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE https://ClinicalTrials.gov/show/NCT03355482 Recruiting Oklahoma Medical Research Foundation 2020-12-31
NCT01992666 GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01992666 Completed Hospices Civils de Lyon 2016-10-31
NCT01988506 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases https://ClinicalTrials.gov/show/NCT01988506 Recruiting Assistance Publique - Hôpitaux de Paris 2020-08-13
NCT01972568 Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01972568 Completed EMD Serono 2016-04-30
NCT01953835 A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184 https://ClinicalTrials.gov/show/NCT01953835 Completed GlaxoSmithKline 2014-03-10
NCT01911169 Vitamin D to Improve Endothelial Function in SLE https://ClinicalTrials.gov/show/NCT01911169 Completed Medical University of South Carolina 2014-01-31
NCT01904812 Longitudinal Study of Quality of Life and Activity in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01904812 Completed Centre Hospitalier Universitaire Dijon 2015-05-31
NCT01894360 A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects https://ClinicalTrials.gov/show/NCT01894360 Completed GlaxoSmithKline 2014-05-13
NCT01892748 Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus. https://ClinicalTrials.gov/show/NCT01892748 Completed University of Sao Paulo 2013-08-31
NCT01852851 Employment and Arthritis: Making it Work https://ClinicalTrials.gov/show/NCT01852851 Active, not recruiting University of British Columbia 2020-06-30
NCT01841619 IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01841619 Completed University of California, Irvine 2014-11-30
NCT01838694 Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. https://ClinicalTrials.gov/show/NCT01838694 Completed Invion, Inc. 2015-08-31
NCT01837875 Intervention to Improve Quality of Life in African American Lupus Patients https://ClinicalTrials.gov/show/NCT01837875 Completed Medical University of South Carolina 2016-06-30
NCT01764594 Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01764594 Completed UCB Pharma 2014-08-31
NCT01753401 Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease https://ClinicalTrials.gov/show/NCT01753401 Completed Mallinckrodt 2015-10-31
NCT01753193 An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults https://ClinicalTrials.gov/show/NCT01753193 Completed MedImmune LLC 2018-07-18
NCT01741012 Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients https://ClinicalTrials.gov/show/NCT01741012 Completed Wayne State University 2015-01-31
NCT01705977 Belimumab Assessment of Safety in SLE https://ClinicalTrials.gov/show/NCT01705977 Active, not recruiting GlaxoSmithKline 2018-07-30
NCT01702740 A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01702740 Completed Centocor Research & Development, Inc. 2009-10-31
NCT01689350 A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment https://ClinicalTrials.gov/show/NCT01689350 Completed Sun Yat-sen University 2013-12-31
NCT01687309 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender https://ClinicalTrials.gov/show/NCT01687309 Completed GlaxoSmithKline 2012-07-31
NCT01686555 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01686555 Completed AbbVie 2015-06-30
NCT01683695 Safety Study of AMG 557 in Subjects With Lupus Arthritis https://ClinicalTrials.gov/show/NCT01683695 Completed Amgen 2016-03-31
NCT01649765 Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy https://ClinicalTrials.gov/show/NCT01649765 Active, not recruiting GlaxoSmithKline 2018-01-24
NCT01632241 Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01632241 Completed GlaxoSmithKline 2018-06-18
NCT01629784 Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01629784 Completed Northwestern University 2013-01-31
NCT01597622 BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 https://ClinicalTrials.gov/show/NCT01597622 Completed GlaxoSmithKline 2018-09-13
NCT01597492 A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01597492 Completed GlaxoSmithKline 2015-09-01
NCT01597050 Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions https://ClinicalTrials.gov/show/NCT01597050 Completed Rigel Pharmaceuticals 2013-09-30
NCT01582880 Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis https://ClinicalTrials.gov/show/NCT01582880 Completed Massachusetts Eye and Ear Infirmary 2014-03-31
NCT01559090 Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. https://ClinicalTrials.gov/show/NCT01559090 Completed AstraZeneca 2014-08-19
NCT01551069 Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion https://ClinicalTrials.gov/show/NCT01551069 Completed Sanofi 2013-12-31
NCT01534403 Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects https://ClinicalTrials.gov/show/NCT01534403 Completed UCB Pharma 2015-02-28
NCT01516450 Japanese phase1 Study of Belimumab (IV vs SC) https://ClinicalTrials.gov/show/NCT01516450 Completed GlaxoSmithKline 2012-04-11
NCT01484496 A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01484496 Completed GlaxoSmithKline 2015-02-13
NCT01474720 Zostavax in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01474720 Completed Oklahoma Medical Research Foundation 2012-07-31
NCT01449071 Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01449071 Completed UCB Pharma 2013-03-31
NCT01438489 A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01438489 Completed MedImmune LLC 2015-04-30
NCT01425775 The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01425775 Completed University of Alexandria 2010-09-30
NCT01408576 Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01408576 Completed UCB Pharma 2016-02-29
NCT01405196 Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01405196 Completed Pfizer 2014-03-31
NCT01395745 CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01395745 Completed Anthera Pharmaceuticals 2016-07-31
NCT01381536 Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01381536 Completed GlaxoSmithKline 2010-11-27
NCT01352988 Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01352988 Completed University Hospital Muenster 2013-10-31
NCT01351662 Balancing Lupus Experiences With Stress Strategies https://ClinicalTrials.gov/show/NCT01351662 Completed Medical University of South Carolina 2011-10-31
NCT01345253 GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia https://ClinicalTrials.gov/show/NCT01345253 Completed GlaxoSmithKline 2015-09-15
NCT01322308 Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01322308 Completed National Heart Institute, Mexico 2012-01-31
NCT03575156 Microparticles’s Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis https://ClinicalTrials.gov/show/NCT03575156 Recruiting University Hospital, Bordeaux 2021-09-30
NCT04305418 Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients https://ClinicalTrials.gov/show/NCT04305418 Completed Bar-Ilan University, Israel 2018-09-04
NCT04275193 The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04275193 Recruiting Shanghai University of Traditional Chinese Medicine 2022-03-01
NCT04244539 Efficacy of High-intensity Laser in Jaccoud’s Arthropathy in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04244539 Completed Jouf University 2019-10-30
NCT04233164 Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04233164 Recruiting National Institutes of Health Clinical Center (CC) 2024-02-29
NCT04186871 Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT04186871 Recruiting Bristol-Myers Squibb 2022-06-23
NCT04179032 Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT04179032 Recruiting GlaxoSmithKline 2023-03-08
NCT04136145 Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects https://ClinicalTrials.gov/show/NCT04136145 Completed GlaxoSmithKline 2020-01-14
NCT04128579 Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis https://ClinicalTrials.gov/show/NCT04128579 Recruiting Equillium 2021-06-30
NCT04127747 Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04127747 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2022-12-31
NCT04082416 Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) https://ClinicalTrials.gov/show/NCT04082416 Recruiting RemeGen 2021-10-31
NCT04077684 Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial https://ClinicalTrials.gov/show/NCT04077684 Recruiting Peking University People’s Hospital 2024-08-31
NCT04058028 Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT04058028 Active, not recruiting Amgen 2022-11-14
NCT04035265 Application of MRI for Musculoskeletal Involvement in SLE https://ClinicalTrials.gov/show/NCT04035265 Recruiting Hospital del Mar 2020-01-31
NCT03979976 Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03979976 Completed Federal University of São Paulo 2013-08-31
NCT03953261 Effect of Curcumin on Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03953261 Recruiting Loma Linda University 2020-04-01
NCT03951259 Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03951259 Recruiting RenJi Hospital 2020-12-31
NCT03949426 Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects https://ClinicalTrials.gov/show/NCT03949426 Completed Kangpu Biopharmaceuticals, Ltd. 2019-09-29
NCT03942718 Systemic Lupus Erythematosus Exercise Program https://ClinicalTrials.gov/show/NCT03942718 Recruiting University Medical Center Mainz 2019-08-01
NCT03938324 Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions https://ClinicalTrials.gov/show/NCT03938324 Recruiting Duke University 2024-02-29
NCT03937856 Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03937856 Enrolling by invitation Johns Hopkins University 2021-05-31
NCT03933839 Internet-Based Pain Coping Skills Training for Patients With Lupus https://ClinicalTrials.gov/show/NCT03933839 Completed University of North Carolina, Chapel Hill 2020-04-22
NCT03917797 Mesenchymal Stromal Cells (MSC´s) in Renal Lupus https://ClinicalTrials.gov/show/NCT03917797 Recruiting Universidad de los Andes, Chile 2022-12-31
NCT03878303 Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03878303 Recruiting ACEA Therapeutics, Inc. 2020-12-31
NCT03866317 A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03866317 Recruiting Massachusetts General Hospital 2020-05-31
NCT03845517 A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) https://ClinicalTrials.gov/show/NCT03845517 Recruiting Pfizer 2022-09-07
NCT03817424 A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis https://ClinicalTrials.gov/show/NCT03817424 Active, not recruiting Viela Bio 2020-06-30
NCT03816345 Nivolumab in Treating Patients With Autoimmune Disorders or Advanced, Metastatic, or Unresectable Cancer https://ClinicalTrials.gov/show/NCT03816345 Recruiting National Cancer Institute (NCI) 2022-08-31
NCT03802578 The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE’ Patients https://ClinicalTrials.gov/show/NCT03802578 Completed National and Kapodistrian University of Athens 2018-06-30
NCT03747159 Synergetic B-cell Immunomodulation in SLE - 2nd Study. https://ClinicalTrials.gov/show/NCT03747159 Recruiting Leiden University Medical Center 2020-10-31
NCT03746197 Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03746197 Active, not recruiting National Jewish Health 2019-09-30
NCT03738826 Reducing Disparities in Medication Adherence in SLE https://ClinicalTrials.gov/show/NCT03738826 Active, not recruiting Duke University 2020-06-30
NCT03734055 Peer Approaches to Lupus Self-management https://ClinicalTrials.gov/show/NCT03734055 Recruiting Medical University of South Carolina 2023-06-30
NCT03724916 A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03724916 Active, not recruiting Takeda 2021-11-01
NCT03656627 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease https://ClinicalTrials.gov/show/NCT03656627 Recruiting Alliance Foundation Trials, LLC. 2022-10-31
NCT03656562 Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients https://ClinicalTrials.gov/show/NCT03656562 Recruiting Novartis 2021-08-13
NCT03626311 Omega-3 Replacement With Krill Oil in Disease Management of SLE https://ClinicalTrials.gov/show/NCT03626311 Recruiting Aker Biomarine Antarctic AS 2020-06-30
NCT03618056 Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03618056 Active, not recruiting National Institute of Allergy and Infectious Diseases (NIAID) 2020-09-15
NCT03556007 A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03556007 Completed Eli Lilly and Company 2019-08-29
NCT03541564 An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects https://ClinicalTrials.gov/show/NCT03541564 Completed Bristol-Myers Squibb 2018-09-04
NCT03537638 Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE https://ClinicalTrials.gov/show/NCT03537638 Active, not recruiting Servicio Canario de Salud 2020-12-31
NCT03527472 Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03527472 Active, not recruiting Vanderbilt University Medical Center 2022-10-31
NCT03492255 CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid https://ClinicalTrials.gov/show/NCT03492255 Recruiting University of Sao Paulo General Hospital 2018-10-30
NCT03427151 Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03427151 Completed ImmuPharma 2019-02-05
NCT03426384 FLARE Lupus Research Study Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03426384 Completed Mymee Inc. 2018-09-05
NCT03421184 Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03421184 Recruiting University Hospital, Bordeaux 2020-11-30
NCT01262365 Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01262365 Completed UCB Pharma 2015-05-31
NCT01261793 Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01261793 Completed UCB Pharma 2015-05-31
NCT01769937 Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01769937 Completed Fiechtner, Justus J., M.D., P.C. 2013-04-30
NCT01205438 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01205438 Completed Eli Lilly and Company 2014-08-31
NCT01196091 A Study of LY2127399 in Participants With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01196091 Completed Eli Lilly and Company 2014-07-31
NCT01170585 A Trial of Rosuvastatin in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01170585 Completed Imperial College London 2014-05-31
NCT01162681 PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01162681 Completed Anthera Pharmaceuticals 2012-04-30
NCT01146444 Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) https://ClinicalTrials.gov/show/NCT01146444 Completed Spirig Pharma Ltd. 2011-09-30
NCT01135459 A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01135459 Completed Teva Pharmaceutical Industries 2012-01-31
NCT01120652 Reducing Depressive Symptoms in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01120652 Completed University of Pittsburgh 2015-06-30
NCT01112215 Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations https://ClinicalTrials.gov/show/NCT01112215 Completed Hospital Universitari Vall d’Hebron Research Institute 2015-12-31
NCT01101802 Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) https://ClinicalTrials.gov/show/NCT01101802 Completed Guy’s and St Thomas’ NHS Foundation Trust 2008-03-31
NCT01093911 Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01093911 Completed UCB Pharma 2012-12-31
NCT01085097 Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis https://ClinicalTrials.gov/show/NCT01085097 Completed Teva Pharmaceutical Industries 2012-09-30
NCT01085084 Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis https://ClinicalTrials.gov/show/NCT01085084 Completed Teva Pharmaceutical Industries 2012-08-31
NCT01072734 Auto-immunity in Lupus Patients After Influenza Vaccine https://ClinicalTrials.gov/show/NCT01072734 Completed Assistance Publique - Hôpitaux de Paris 2010-01-31
NCT01058343 Safety of IFNa Kinoid in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01058343 Completed Neovacs 2011-04-30
NCT01031836 A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. https://ClinicalTrials.gov/show/NCT01031836 Completed AstraZeneca 2012-11-07
NCT00997100 Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00997100 Completed Active Biotech AB 2010-09-30
NCT00987831 Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00987831 Completed Oklahoma Medical Research Foundation 2012-12-31
NCT00979654 A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis https://ClinicalTrials.gov/show/NCT00979654 Completed MedImmune LLC 2015-03-31
NCT00976729 NOX-E36 First-in-Human (FIH) Study https://ClinicalTrials.gov/show/NCT00976729 Completed NOXXON Pharma AG 2009-12-31
NCT00976300 Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study https://ClinicalTrials.gov/show/NCT00976300 Completed Institute of Rheumatology, Prague 2008-05-31
NCT00962832 A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00962832 Completed Genentech, Inc. 2012-01-31
NCT00960362 An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00960362 Completed Argos Therapeutics 2011-12-31
NCT02021513 Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02021513 Completed University of Texas Southwestern Medical Center 2013-06-30
NCT00911521 Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study https://ClinicalTrials.gov/show/NCT00911521 Completed Tuen Mun Hospital 2011-03-31
NCT00858884 Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00858884 Completed University of New Mexico 2012-07-31
NCT02811094 LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse https://ClinicalTrials.gov/show/NCT02811094 Recruiting Assistance Publique Hopitaux De Marseille 2020-07-31
NCT00828178 Efficacy of Fish Oil in Lupus Patients https://ClinicalTrials.gov/show/NCT00828178 Completed Johns Hopkins University 2011-02-28
NCT02880852 Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02880852 Completed GlaxoSmithKline 2017-09-08
NCT00815282 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT00815282 Completed UMC Utrecht 2015-01-31
NCT03978520 A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT03978520 Recruiting AbbVie 2021-09-16
NCT04400240 Care Coordination Approaches to Learning Lupus Self-management https://ClinicalTrials.gov/show/NCT04400240 Completed Medical University of South Carolina 2019-12-31
NCT03189017 A Phase I Study of ICP-022 in Healthy Subjects https://ClinicalTrials.gov/show/NCT03189017 Completed Innocare Pharma Australia Pty Ltd 2018-02-05
NCT03334851 Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT03334851 Recruiting Pfizer 2022-05-27
NCT02988661 Women Empowered to Live With Lupus Study https://ClinicalTrials.gov/show/NCT02988661 Recruiting Emory University 2021-08-31
NCT03107442 Exercise and Arterial Stiffness in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03107442 Completed Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental 2017-07-21
NCT02349061 A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02349061 Completed Janssen Research & Development, LLC 2017-05-15
NCT01781611 Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01781611 Completed Oklahoma Medical Research Foundation 2017-05-31
NCT01327352 Evaluation of the Influence of Food Regimen on Oshadi D Absorption https://ClinicalTrials.gov/show/NCT01327352 Completed Oshadi Drug Administration 2011-08-31
NCT00786409 Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women https://ClinicalTrials.gov/show/NCT00786409 Completed University of Chicago 2010-08-31
NCT00779194 Prospective Study of Rapamycin for the Treatment of SLE https://ClinicalTrials.gov/show/NCT00779194 Completed State University of New York - Upstate Medical University 2015-12-31
NCT00774943 A Study of AMG 557 in Adults With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00774943 Completed Amgen 2012-05-31
NCT00774852 Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis https://ClinicalTrials.gov/show/NCT00774852 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2012-12-31
NCT00750971 Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) https://ClinicalTrials.gov/show/NCT00750971 Recruiting Charite University, Berlin, Germany 2020-07-31
NCT00731302 Aspirin Resistance in Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00731302 Completed Vanderbilt University Medical Center 2017-04-30
NCT00730002 Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus https://ClinicalTrials.gov/show/NCT00730002 Completed University of Michigan 2014-09-30
NCT00724867 A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States https://ClinicalTrials.gov/show/NCT00724867 Completed GlaxoSmithKline 2015-03-31
NCT00714116 Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00714116 Completed Pfizer 2012-09-30
NCT00712933 A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 https://ClinicalTrials.gov/show/NCT00712933 Completed GlaxoSmithKline 2016-12-09
NCT00710021 Vitamin D3 in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00710021 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-07-31
NCT00668330 Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00668330 Completed Chinese University of Hong Kong 2009-05-31
NCT00660881 Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease https://ClinicalTrials.gov/show/NCT00660881 Completed UCB Pharma 2011-12-31
NCT00657189 A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus https://ClinicalTrials.gov/show/NCT00657189 Completed MedImmune LLC 2010-05-31
NCT00657007 Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00657007 Completed Human Genome Sciences Inc. 2003-03-31
NCT00637819 Leflunomide in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00637819 Completed Sanofi NA
NCT00633945 Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) https://ClinicalTrials.gov/show/NCT00633945 Completed University of Pennsylvania 2009-07-31
NCT00626197 A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) https://ClinicalTrials.gov/show/NCT00626197 Completed Genentech, Inc. 2009-10-31
NCT00625521 Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions https://ClinicalTrials.gov/show/NCT00625521 Completed Astion Pharma A/S NA
NCT00625157 Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2) https://ClinicalTrials.gov/show/NCT00625157 Completed Astion Pharma A/S NA
NCT00624351 Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease https://ClinicalTrials.gov/show/NCT00624351 Completed UCB Pharma 2009-08-31
NCT00624338 Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) https://ClinicalTrials.gov/show/NCT00624338 Completed EMD Serono 2012-04-30
NCT00611663 Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00611663 Completed Assistance Publique - Hôpitaux de Paris 2014-12-31
NCT00608673 Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00608673 Completed Shahid Beheshti University of Medical Sciences 2007-07-31
NCT00594932 Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis https://ClinicalTrials.gov/show/NCT00594932 Completed Oklahoma Medical Research Foundation 2008-07-31
NCT00588393 FolateScan in Autoimmune Disease https://ClinicalTrials.gov/show/NCT00588393 Completed Mayo Clinic 2007-12-31
NCT00583362 A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 https://ClinicalTrials.gov/show/NCT00583362 Completed GlaxoSmithKline 2016-02-23
NCT00556192 Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00556192 Completed Chinese University of Hong Kong 2009-12-31
NCT00541749 A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00541749 Completed Genentech, Inc. NA
NCT00523588 Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser https://ClinicalTrials.gov/show/NCT00523588 Completed University of Pennsylvania 2009-02-28
NCT01176643 Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01176643 Completed McGill University Health Centre/Research Institute of the McGill University Health Centre 2012-05-31
NCT00519363 Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors https://ClinicalTrials.gov/show/NCT00519363 Completed The Center for Rheumatic Disease, Allergy, & Immunology 2008-10-31
NCT00493753 Feasibility and Safety of Acupuncture for Systemic Lupus https://ClinicalTrials.gov/show/NCT00493753 Completed University of Pittsburgh NA
NCT00483613 Effects of Treatment of Chronic Stress in Patients With Lupus https://ClinicalTrials.gov/show/NCT00483613 Completed University Hospital Virgen de las Nieves NA
NCT00482989 A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00482989 Completed MedImmune LLC 2010-07-31
NCT00470522 Study of Methotrexate in Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00470522 Completed University Health Network, Toronto NA
NCT00418587 Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00418587 Completed Medical University of South Carolina 2008-08-31
NCT00417430 Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies https://ClinicalTrials.gov/show/NCT00417430 Completed The Center for Rheumatic Disease, Allergy, & Immunology 2006-12-31
NCT00413361 The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS https://ClinicalTrials.gov/show/NCT00413361 Completed Assistance Publique - Hôpitaux de Paris 2011-01-31
NCT00410384 A Study of Belimumab in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00410384 Completed Human Genome Sciences Inc. 2009-09-30
NCT00401141 Abnormalities of B Lymphocytes During Systemic Lupus https://ClinicalTrials.gov/show/NCT00401141 Completed University Hospital, Strasbourg, France NA
NCT00392951 Sirolimus for Autoimmune Disease of Blood Cells https://ClinicalTrials.gov/show/NCT00392951 Completed Children’s Hospital of Philadelphia 2016-02-29
NCT00392093 Effect of Hormone Replacement Therapy on Lupus Activity https://ClinicalTrials.gov/show/NCT00392093 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran NA
NCT00391924 Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren’s Syndrome https://ClinicalTrials.gov/show/NCT00391924 Completed UMC Utrecht NA
NCT00383513 Study of Epratuzumab in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00383513 Completed UCB Pharma 2012-01-31
NCT00371501 Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00371501 Completed Tuen Mun Hospital 2009-12-31
NCT00317681 Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) https://ClinicalTrials.gov/show/NCT00317681 Completed Heinrich-Heine University, Duesseldorf NA
NCT00299819 Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00299819 Completed MedImmune LLC NA
NCT00293072 Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis https://ClinicalTrials.gov/show/NCT00293072 Completed Cambridge University Hospitals NHS Foundation Trust NA
NCT00278538 Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00278538 Completed Northwestern University 2018-12-31
NCT00271934 Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study https://ClinicalTrials.gov/show/NCT00271934 Completed Northwestern University 2007-11-30
NCT00189124 Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention https://ClinicalTrials.gov/show/NCT00189124 Completed University of Michigan 2005-12-31
NCT00181298 Memantine in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00181298 Completed Johns Hopkins University 2007-05-31
NCT00155532 Skin Denervation in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00155532 Completed National Taiwan University Hospital NA
NCT00137969 A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00137969 Completed Genentech, Inc. 2008-08-25
NCT00125307 Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis https://ClinicalTrials.gov/show/NCT00125307 Completed Chinese University of Hong Kong 2007-10-31
NCT00124514 Triptorelin for Ovary Protection in Childhood Onset Lupus https://ClinicalTrials.gov/show/NCT00124514 Completed Children’s Hospital Medical Center, Cincinnati 2014-03-31
NCT00120887 Lupus Atherosclerosis Prevention Study https://ClinicalTrials.gov/show/NCT00120887 Completed Johns Hopkins University NA
NCT00119678 Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone https://ClinicalTrials.gov/show/NCT00119678 Completed Bristol-Myers Squibb 2008-11-30
NCT00094380 Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) https://ClinicalTrials.gov/show/NCT00094380 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2006-01-31
NCT00082511 GL701 (Prestaraâ„¢) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids https://ClinicalTrials.gov/show/NCT00082511 Completed Genelabs Technologies 2005-08-31
NCT00076752 Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00076752 Completed National Institutes of Health Clinical Center (CC) 2013-10-15
NCT00071487 Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00071487 Completed Human Genome Sciences Inc. 2005-08-31
NCT00065806 Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) https://ClinicalTrials.gov/show/NCT00065806 Completed Duke University 2009-12-31
NCT00054938 Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) https://ClinicalTrials.gov/show/NCT00054938 Completed Brigham and Women’s Hospital 2005-12-31
NCT00818948 Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis https://ClinicalTrials.gov/show/NCT00818948 Completed Amgen 2014-06-30
NCT00001680 A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00001680 Completed National Institutes of Health Clinical Center (CC) NA
NCT00046774 Monoclonal Antibody Treatment for Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00046774 Completed National Institutes of Health Clinical Center (CC) 2007-01-01
NCT00036491 Anti-CD20 in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00036491 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2006-01-31
NCT00035308 Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease https://ClinicalTrials.gov/show/NCT00035308 Completed La Jolla Pharmaceutical Company NA
NCT00025818 Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome https://ClinicalTrials.gov/show/NCT00025818 Completed Allergan 2003-03-31
NCT00723671 Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus https://ClinicalTrials.gov/show/NCT00723671 Completed University of Michigan 2013-04-30
NCT00424476 A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT00424476 Completed Human Genome Sciences Inc. 2009-05-31
NCT00011908 Humanized LL2IGG to Treat Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00011908 Completed National Institutes of Health Clinical Center (CC) NA
NCT00010400 Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome https://ClinicalTrials.gov/show/NCT00010400 Completed Office of Rare Diseases (ORD) NA
NCT00010335 Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders https://ClinicalTrials.gov/show/NCT00010335 Completed Fred Hutchinson Cancer Research Center 2010-07-31
NCT00006133 Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00006133 Completed National Center for Research Resources (NCRR) NA
NCT00005778 High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide https://ClinicalTrials.gov/show/NCT00005778 Completed National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2006-04-30
NCT00004795 Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00004795 Completed Office of Rare Diseases (ORD) NA
NCT00004756 Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00004756 Completed Office of Rare Diseases (ORD) NA
NCT00004665 Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00004665 Completed Office of Rare Diseases (ORD) NA
NCT00004662 Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00004662 Completed Office of Rare Diseases (ORD) NA
NCT00004643 Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00004643 Completed Office of Rare Diseases (ORD) NA
NCT00001676 Cyclophosphamide and Fludarabine to Treat Lupus Nephritis https://ClinicalTrials.gov/show/NCT00001676 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001212 Drug Therapy in Lupus Nephropathy https://ClinicalTrials.gov/show/NCT00001212 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000421 Serologically Active, Clinically Stable Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00000421 Completed NYU Langone Health 2002-08-31
NCT00000420 Safety of Estrogens in Lupus: Birth Control Pills https://ClinicalTrials.gov/show/NCT00000420 Completed NYU Langone Health NA
NCT00000417 Psychoeducational Approach to Improve Health in Lupus https://ClinicalTrials.gov/show/NCT00000417 Completed Brigham and Women’s Hospital 2001-03-31
NCT00000416 Prevention of Arthritis-Related Work Disability https://ClinicalTrials.gov/show/NCT00000416 Completed Boston University Charles River Campus 2001-08-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03370263 BENLYSTA® Special Drug Use Investigation https://ClinicalTrials.gov/show/NCT03370263 Recruiting GlaxoSmithKline 2025-06-26
NCT03206359 GADD34 and Type I IFN Response Genes in SLE https://ClinicalTrials.gov/show/NCT03206359 Completed University Hospital, Grenoble 2015-04-03
NCT03179046 Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03179046 Completed Assiut University 2019-04-01
NCT03142711 Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03142711 Completed Lupus Research Alliance 2018-07-03
NCT03142412 Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization https://ClinicalTrials.gov/show/NCT03142412 Active, not recruiting DxTerity Diagnostics 2021-10-17
NCT03063281 Anti-ficolin-2 Autoantibodies in Lupus Nephritis https://ClinicalTrials.gov/show/NCT03063281 Completed University Hospital, Grenoble 2013-05-31
NCT02920346 Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor https://ClinicalTrials.gov/show/NCT02920346 Active, not recruiting University of Colorado, Denver 2020-12-31
NCT02769195 Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE https://ClinicalTrials.gov/show/NCT02769195 Completed Monash University 2019-01-31
NCT02655640 The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis https://ClinicalTrials.gov/show/NCT02655640 Completed Universitaire Ziekenhuizen Leuven 2017-03-31
NCT02625831 Anti-ficolin-3 Autoantibodies in Lupus Nephritis https://ClinicalTrials.gov/show/NCT02625831 Completed University Hospital, Grenoble 2013-05-31
NCT00055055 Study of Families With Twins or Siblings Discordant for Rheumatic Disorders https://ClinicalTrials.gov/show/NCT00055055 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001372 Study of Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00001372 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02530944 Web-based Genetic Research on Lupus https://ClinicalTrials.gov/show/NCT02530944 Completed 23andMe, Inc. 2017-10-31
NCT02477254 Long-term Immunogenicity of a HPV Vaccine in SLE https://ClinicalTrials.gov/show/NCT02477254 Completed Tuen Mun Hospital 2016-05-31
NCT02466217 Phenomics in Autoimmune and Inflammatory Diseases https://ClinicalTrials.gov/show/NCT02466217 Recruiting Assistance Publique - Hôpitaux de Paris 2022-07-31
NCT02456168 Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT02456168 Active, not recruiting Northwell Health 2021-12-31
NCT02403115 Prediction of Outcome of Lupus Nephritis https://ClinicalTrials.gov/show/NCT02403115 Recruiting Istituto Giannina Gaslini 2019-11-30
NCT02350491 Study During Pregnancy of Expression of miRNAs in RA or SLE https://ClinicalTrials.gov/show/NCT02350491 Completed University Hospital, Strasbourg, France 2018-10-14
NCT02217137 Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients https://ClinicalTrials.gov/show/NCT02217137 Completed Singapore National Eye Centre 2015-09-30
NCT02162992 Systemic Lupus Erythematous and Heart Conduction Disorders https://ClinicalTrials.gov/show/NCT02162992 Completed Germans Trias i Pujol Hospital 2017-11-30
NCT02125695 Pilot Tape Harvesting Study https://ClinicalTrials.gov/show/NCT02125695 Completed Biogen 2016-08-31
NCT02034344 A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers https://ClinicalTrials.gov/show/NCT02034344 Completed Janssen Research & Development, LLC 2015-05-31
NCT02006784 Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02006784 Completed Vanderbilt University Medical Center 2014-04-30
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01923415 A Non-drug Study Profiling Cutaneous Lupus https://ClinicalTrials.gov/show/NCT01923415 Completed Janssen Research & Development, LLC 2014-08-31
NCT01914770 Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 https://ClinicalTrials.gov/show/NCT01914770 Completed GlaxoSmithKline 2010-11-30
NCT01642706 Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments https://ClinicalTrials.gov/show/NCT01642706 Recruiting University Hospital, Montpellier 2020-10-31
NCT01616472 WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) https://ClinicalTrials.gov/show/NCT01616472 Completed GlaxoSmithKline 2016-01-31
NCT01549184 Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01549184 Completed Henri Mondor University Hospital 2011-12-31
NCT01520155 CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE) https://ClinicalTrials.gov/show/NCT01520155 Completed Johann Wolfgang Goethe University Hospital 2012-12-31
NCT01510067 Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01510067 Recruiting University of Pennsylvania 2025-08-31
NCT01509989 International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01509989 Completed Assistance Publique - Hôpitaux de Paris 2015-12-31
NCT01475149 Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01475149 Completed Hospital for Special Surgery, New York 2013-09-30
NCT01413230 Vitamin D Supplementation in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01413230 Completed Assistance Publique - Hôpitaux de Paris 2011-01-31
NCT01330368 Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children https://ClinicalTrials.gov/show/NCT01330368 Completed Children’s Hospital of Philadelphia 2013-07-31
NCT04449653 Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals https://ClinicalTrials.gov/show/NCT04449653 Recruiting Progentec Diagnostics, Inc. 2020-12-31
NCT04361734 The Role of Lipids in Immune Cell Function in SLE Patients https://ClinicalTrials.gov/show/NCT04361734 Recruiting University College, London 2020-08-31
NCT04356014 Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04356014 Active, not recruiting University Hospital, Montpellier 2020-11-30
NCT04355702 Covid-19 in Lupus Patients https://ClinicalTrials.gov/show/NCT04355702 Recruiting University Hospital, Montpellier 2020-12-01
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease https://ClinicalTrials.gov/show/NCT04345159 Active, not recruiting Fondation Ophtalmologique Adolphe de Rothschild 2020-04-30
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases https://ClinicalTrials.gov/show/NCT04335747 Recruiting Aalborg University Hospital 2021-08-01
NCT04213690 A Pilot Study to Explore the Role of Gut Flora in Lupus https://ClinicalTrials.gov/show/NCT04213690 Recruiting ProgenaBiome 2023-03-31
NCT04022655 Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit https://ClinicalTrials.gov/show/NCT04022655 Recruiting University of Göttingen 2019-08-31
NCT03941184 Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity https://ClinicalTrials.gov/show/NCT03941184 Recruiting Mayo Clinic 2020-12-31
NCT03896373 Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus https://ClinicalTrials.gov/show/NCT03896373 Recruiting University Hospital, Tours 2020-04-30
NCT03842787 Anti-ficolin-3 Antibodies in Lupus Nephritis https://ClinicalTrials.gov/show/NCT03842787 Recruiting University Hospital, Grenoble 2020-06-30
NCT03802188 Hydroxychloroquine in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03802188 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2024-03-31
NCT03757065 Cell Surface Marker Expression in Autoimmune Diseases https://ClinicalTrials.gov/show/NCT03757065 Enrolling by invitation Alpine Immune Sciences, Inc. 2020-03-31
NCT03735238 Implementing the Decision-Aid for Lupus (IDEAL Strategy) https://ClinicalTrials.gov/show/NCT03735238 Recruiting University of Alabama at Birmingham 2021-12-31
NCT03687138 Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques https://ClinicalTrials.gov/show/NCT03687138 Recruiting Hospital de Basurto 2019-06-15
NCT03504540 Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal “Pseudo-drusen-like” Deposits: Case-control Study (PL-AMD) https://ClinicalTrials.gov/show/NCT03504540 Recruiting Fondation Ophtalmologique Adolphe de Rothschild 2021-04-30
NCT03446339 Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) https://ClinicalTrials.gov/show/NCT03446339 Recruiting The University of Hong Kong 2020-08-31
NCT01230112 The Role of ITGAM in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT01230112 Completed Northwell Health 2012-04-30
NCT01157468 Catalytic Antibodies and Lupus in Martinique https://ClinicalTrials.gov/show/NCT01157468 Completed University Hospital Center of Martinique 2013-12-31
NCT01060410 Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment https://ClinicalTrials.gov/show/NCT01060410 Completed Sun Yat-sen University 2012-06-30
NCT01031797 QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT01031797 Completed Shiraz University of Medical Sciences 2009-03-31
NCT00982670 A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00982670 Completed Far Eastern Memorial Hospital 2008-12-31
NCT04089930 Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients https://ClinicalTrials.gov/show/NCT04089930 Recruiting Tuen Mun Hospital 2021-02-01
NCT04018222 Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic https://ClinicalTrials.gov/show/NCT04018222 Recruiting Progentec Diagnostics, Inc. 2020-03-31
NCT03937271 Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome https://ClinicalTrials.gov/show/NCT03937271 Active, not recruiting Taipei Veterans General Hospital, Taiwan 2019-05-31
NCT02782039 Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE) https://ClinicalTrials.gov/show/NCT02782039 Recruiting Assistance Publique - Hôpitaux de Paris 2021-11-30
NCT03189875 Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) https://ClinicalTrials.gov/show/NCT03189875 Active, not recruiting AstraZeneca 2022-12-01
NCT00756769 Systemic Lupus Erythematosus in Gullah Health https://ClinicalTrials.gov/show/NCT00756769 Recruiting Medical University of South Carolina 2021-06-30
NCT00611611 BLYS and IFN in SLE https://ClinicalTrials.gov/show/NCT00611611 Completed University of Alabama at Birmingham 2009-04-30
NCT00582881 Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00582881 Recruiting University of Miami 2022-07-31
NCT00582465 Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00582465 Completed University of California, San Francisco 2004-07-09
NCT00563082 Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00563082 Completed University of Pittsburgh NA
NCT00544102 Insulin Resistance and Atherosclerosis in Women With Lupus https://ClinicalTrials.gov/show/NCT00544102 Completed National Institutes of Health Clinical Center (CC) NA
NCT00522002 CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study https://ClinicalTrials.gov/show/NCT00522002 Completed George Washington University 2010-06-30
NCT00513591 Duke Autoimmunity in Pregnancy Registry https://ClinicalTrials.gov/show/NCT00513591 Completed Duke University 2018-11-19
NCT00512694 Duke Lupus Registry https://ClinicalTrials.gov/show/NCT00512694 Recruiting Duke University 2025-06-30
NCT00420173 Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) https://ClinicalTrials.gov/show/NCT00420173 Completed European Society of Cutaneous Lupus Erythematosus e.V. 2005-07-31
NCT00342095 Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study https://ClinicalTrials.gov/show/NCT00342095 Completed National Institutes of Health Clinical Center (CC) NA
NCT00280137 Health-related Quality of Life Measure in Pediatric Lupus https://ClinicalTrials.gov/show/NCT00280137 Completed Rutgers, The State University of New Jersey 2012-11-30
NCT00235378 Genetic Study of Lupus Patients and Their Families https://ClinicalTrials.gov/show/NCT00235378 Completed Oklahoma Medical Research Foundation 2013-03-31
NCT00198068 Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) https://ClinicalTrials.gov/show/NCT00198068 Recruiting Hospital for Special Surgery, New York 2020-08-31
NCT00074373 The Research Registry for Neonatal Lupus https://ClinicalTrials.gov/show/NCT00074373 Active, not recruiting NYU Langone Health 2016-06-30
NCT00071175 Lupus Genetics Studies https://ClinicalTrials.gov/show/NCT00071175 Completed Oklahoma Medical Research Foundation 2012-09-30
NCT00069342 Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases https://ClinicalTrials.gov/show/NCT00069342 Completed National Institutes of Health Clinical Center (CC) NA
NCT00042523 Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00042523 Completed National Institutes of Health Clinical Center (CC) NA
NCT00029926 Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity https://ClinicalTrials.gov/show/NCT00029926 Completed National Institutes of Health Clinical Center (CC) NA
NCT00006134 Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture https://ClinicalTrials.gov/show/NCT00006134 Completed National Center for Research Resources (NCRR) NA
NCT00005436 Lupus Cohort–Thrombotic Events and Coronary Artery Disease https://ClinicalTrials.gov/show/NCT00005436 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00004663 Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT00004663 Completed Office of Rare Diseases (ORD) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03276923 Maternal Autoimmune Disease Research Alliance (MADRA) Registry https://ClinicalTrials.gov/show/NCT03276923 Recruiting Duke University 2027-01-01
NCT03138941 Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region https://ClinicalTrials.gov/show/NCT03138941 Recruiting Monash University 2025-12-31
NCT01729455 Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry https://ClinicalTrials.gov/show/NCT01729455 Active, not recruiting GlaxoSmithKline 2025-01-16
NCT01697254 The CARRA Registry https://ClinicalTrials.gov/show/NCT01697254 Completed Duke University 2015-10-31
NCT01532310 Belimumab (BENLYSTA®) Pregnancy Registry https://ClinicalTrials.gov/show/NCT01532310 Recruiting GlaxoSmithKline 2021-11-26
NCT04402086 Rheumatology Patient Registry and Biorepository https://ClinicalTrials.gov/show/NCT04402086 Recruiting Yale University 2030-06-01
NCT04037293 Premature Atherosclerosis in Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT04037293 Active, not recruiting Peking Union Medical College Hospital 2021-12-31
NCT03913754 Psycho-social Consequences of Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03913754 Recruiting Assistance Publique Hopitaux De Marseille 2020-07-01
NCT03746028 The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies https://ClinicalTrials.gov/show/NCT03746028 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2023-10-30
NCT03480529 Monitoring the IMmUological TOXicity of Drugs https://ClinicalTrials.gov/show/NCT03480529 Completed Groupe Hospitalier Pitie-Salpetriere 2018-03-10
NCT03473912 Meir Medical Center Rheumatologic Biobank https://ClinicalTrials.gov/show/NCT03473912 Recruiting Meir Medical Center 2037-11-30
NCT01076101 Autoimmunity in Sisters of Lupus Patients https://ClinicalTrials.gov/show/NCT01076101 Completed Northwell Health 2016-12-31
NCT02219269 A Complex Contraception Registry https://ClinicalTrials.gov/show/NCT02219269 Completed University of California, San Diego 2015-06-30